Loading stock…

Labcorp Holdings Inc. (LH) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Labcorp Holdings Inc.

LHMarket cap $25BPrice $312.0

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Runs one of the world's largest clinical laboratory networks, processing billions of diagnostic tests each year. Doctors everywhere rely on its results to catch diseases early, often before patients feel a single symptom.

In Bastion Portfolios?

52W Return+10%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+6%5

Revenue Forecast

Rev CAGR (1y)+6%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+4%4

Earnings Forecast

EPS Growth Y+1+110%10

EPS Growth Y+2+7%6

EPS Growth Y+3+7%6

Quality

Margins

EBIT Margin11%5

Net Income Margin7%4

Free Cash Flow Margin8%5

Debt

Net Debt/EBITDA2.63

Efficiency

ROE12%5

ROA5%6

Earnings Stability55

GEAR+AVERAGE52

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)165

P/E Ratio (Forward 3y)155

P/BV2.95

EV Multiples

EV/EBITDA Fwd125

EV/EBIT Fwd156

Yield

Free Cash Flow Yield4.6%6

Dividend Yield0.9%3

Momentum

Short term

1 month return-4%6

3 month return+13%9

YTD return+25%8

Mid term

Price vs 52wHigh91%9

1 year return+14%6

Long term

3 year return+60%6

5 year return+38%5

Risk Shield

Price Risk

Beta0.39

Volatility24%9

Free Cash Flow

Free Cash Flow Margin8%5

Free Cash Flow Yield4.6%6

Quality

ROCE10%6

Earnings Stability55

Net Debt/EBITDA2.63

02Growth

Is it actually growing, and how fast?

LHLabcorp Holdings

Revenue FY25$13.0B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+6%5

Revenue, next 1Y+6%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+110%10

EPS growth, FY27E+7%6

EPS growth, FY28E+7%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 6%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG75 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return+13%9

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high91%9

1-year return+14%6

3-year return+60%6

5-year return+38%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 14% over the past year, but 9% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+13%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+60% over three years and +38% over five), roughly average for the market.

Returns sit at the market level over the past month (-4%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Labcorp. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

LHLabcorp Holdings

Revenue FY25$13.0B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+6%5

Revenue, next 1Y+6%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+110%10

EPS growth, FY27E+7%6

EPS growth, FY28E+7%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 6%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG75 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return+13%9

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high91%9

1-year return+14%6

3-year return+60%6

5-year return+38%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 14% over the past year, but 9% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+13%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+60% over three years and +38% over five), roughly average for the market.

Returns sit at the market level over the past month (-4%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Labcorp. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community